323
Views
20
CrossRef citations to date
0
Altmetric
Reviews

Can radiation research impact the estimation of risk?

Pages 1009-1014 | Received 11 Oct 2016, Accepted 31 Jan 2017, Published online: 22 Feb 2017

References

  • Adewoye AB, Lindsay SJ, Dubrova YE, Hurles ME. 2015. The genome-wide effects of ionizing radiation on mutation induction in the mammalian germline. Nat Commun. 6:6684.
  • Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, et al. 2010. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 29:730–741.
  • Asakawa J, Kodaira M, Miura A, Tsuji T, Nakamoto Y, Imanaka M, Kitamura J, Cullings H, Nishimura M, Shimada Y, et al. 2016. Genome-wide deletion screening with the array CGH method in mouse offspring derived from irradiated spermatogonia indicates that mutagenic responses are highly variable among genes. Radiat Res. 186:568–576.
  • Behjati S, Gundem G, Wedge DC, Roberts ND, Tarpey PS, Cooke SL, Van Loo P, Alexandrov LB, Ramakrishna M, Davies H, et al. 2015. Mutational signatures of ionizing radiation in second malignancies. Nature Comm. 10:1038.
  • Boss MK, Bristow R, Dewhirst MW. 2014. Linking the history of radiation biology to the hallmarks of cancer. Radiat Res. 181:561–577.
  • Bouville A, Toohey RE, Boice JD Jr, Beck HL, Dauer LT, Eckerman KF, Hagermeyer D, Leggett RW, Mumma MT, Napier B, et al. 2015. Dose reconstruction for the Million Worker Study: status and guidelines. Health Phys. 108:206–220.
  • Brooks AL. 2015. A commentary on: ‘A History of the United States Department of Energy (DOE) Low Dose Radiation Research Program: 1998–2008’. Radiat Res. 183:375–381.
  • Brooks AL, Hoel DG, Preston RJ. 2016. The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation. Int J Radiat Biol. 92:405–426.
  • Cucinotta FA, Kim MHY, Chappell LJ. 2013. Space Radiation Cancer Risk Projections and Uncertainties-2012, NASA/TP-2013-217375. Springfield, VA: National Technical Information Service. [Internet]. Available from: http://www.csc.caltech.edu/references/SpaceRadiationCancerRiskProjectionsandUncertainties.pdf
  • Edwards SW, Tan YM, Villeneuve DL, Meek ME, McQueen CA. 2016. Adverse outcome pathways – organizing toxicological information to improve decision making. J Pharmacol Exp Ther. 356:170–181.
  • Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell. 144:646–674.
  • Heidenreich WF, Rosemann M. 2012. Genetic background and 227Thorium as risk factors in biologically based models for induction of bone cancer in mice. Radiat Environ Biophys. 51:179–185.
  • Heidenreich WF, Saran A, Atkinson M, Pazzaglia S. 2013. A mechanistic model for medulloblastoma induction in mice. Radiat Res. 179:610–614.
  • Heidenreich WF, Tomasek L, Rogel A, Laurier D, Tirmarche M. 2004. Studies of radon-exposed miner cohorts using a biologically based model: comparison of current Czech and French data with historic data from China and Colorado. Radiat Environ Biophys. 43:247–256.
  • International Commission on Radiological Protection (ICRP). 2005. Low-Dose Extrapolation of Radiation-Related Cancer Risk, ICRP Report No. 99, Annals of ICRP. 35(4). New York, NY: Elsevier.
  • International Commission on Radiological Protection (ICRP). 2007. The 2007 Recommendations of the International Commission on Radiological Protection, ICRP Publication 103, Annals of ICRP 37 (2–4). Thousand Oaks, CA: Sage Publications.
  • Kaiser JC, Meckbach R, Eidemuller M, Selmansberger M, Unger K, Shpak V, Blettner M, Zittzelsberger H, Jacob P. 2016. Integration of a radiation biomarker into modeling of thyroid carcinogenesis and post-Chernobyl risk assessment. Carcinogenesis. 37:1152–1160.
  • Krewski D, Zielinski JM, Hazleton WD, Garner MJ, Moolgavkar SH. 2003. The use of biologically based cancer risk models in radiation epidemiology. Radiat Prot Dosimetry. 104:367–376.
  • Laurier D, Richardson DB, Cardis E, Daniels RD, Gillies M, O’Hagan J, Hamra GB, Haylock R, Leuraud K, Moissonnier M, et al. 2016. The International Nuclear Workers Study (INWORKS): a collaborative epidemiological study to improve knowledge about health effects of protracted low-dose exposure. Radiat Prot Dosim. [Epub ahead of print]. doi: 10.1093/rpd/ncw314.
  • Little MP, Haylock RGE, Muirhead CR. 2002. Modelling lung tumour risk in radon-exposed uranium miners using generalizations of the two-mutation model of Moolgavkar, Venzon and Knudson. Int J Radiat Biol. 78:49–68.
  • Meek ME, Boobis A, Cote I, Dellarco V, Fotakis G, Munn S, Seed J, Vickers C. 2014. New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis. J Appl Toxicol. 34:1–18.
  • Moolgavkar SH, Knudson AGJR. 1981. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst. 66:1037–1052.
  • Moolgavkar SH, Venzon DJ. 1979. Two-event models for carcinogenesis: incidence curves for childhood and adult tumors. Math Biosci. 47:55–77.
  • National Council on Radiation Protection and Measurements (NCRP). 1993. Risk Estimates for Radiation Protection, NCRP Report No. 115. Bethesda, MD: NCRP.
  • National Council on Radiation Protection and Measurements (NCRP). 2012. Uncertainties in the Estimation of Radiation Risks and Probability of Disease Causation, NCRP Report No. 171. Bethesda, MD: NCRP.
  • National Council on Radiation Protection and Measurements (NCRP). 2015. Health Effects of Low Doses of Radiation: Perspectives on Integrating Radiation Biology and Epidemiology, NCRP Commentary No. 24. Bethesda, MD: NCRP.
  • National Research Council/National Academy of Sciences (NRC/NAS). 2006. Health Risks from Exposure to Low Levels of Ionizing Radiation, BEIR VII, Phase 2. Washington, DC: National Academies Press.
  • Organization for Economic Co-operation and Development (OECD). 2013. Guidance document on developing and assessing adverse outcome pathways, in Environment Directorate Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Organization for Economic Co-operation and Development. Paris: OECD.
  • Pernot E, Hall J, Baatout S, Benotmane MA, Blanchardon E, Bouffler S, El Saghire H, Gomolka M, Harms-Ringdahl M, Jeggo P, et al. 2012. Ionizing radiation biomarkers for potential use in epidemiological studies. Mutat Res. 751:258–286.
  • Preston RJ. 2003. The LNT model is the best we can do – today. J Radiol Prot. 23:263–268.
  • Preston RJ. 2005. Extrapolations are the Achilles heel of risk assessment. Mutat Res. 589:153–157.
  • Preston RJ. 2015. Integrating basic radiobiological science and epidemiological studies: why and how. Health Phys. 108:125–130.
  • Preston RJ, Williams GM. 2005. DNA-reactive carcinogens: mode of action and human cancer hazard. Crit Rev Toxicol. 35:673–683.
  • United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). 2008. Annex A. Epidemiological studies of radiation and cancer, in effects of ionizing radiation, UNSCEAR 2006 report to the general assembly, with scientific annexes. Volume I: report to the general assembly, scientific annexes A and B. New York, NY: United Nations Publications.
  • U.S. Environmental Protection Agency (EPA). 2005. Guidelines for Carcinogen Risk Assessment, Risk Assessment Forum. Washington, DC: US Environmental Protection Agency. [Internet]. Available from: http://www.epa.gov/cancerguidelines/
  • U.S. Environmental Protection Agency (EPA). 2011. EPA Radiogenic Cancer Risk Models and Projections for the US Population, EPA 402-R-11-001. Washington, DC: US EPA.
  • Verbiest T, Bouffler S, Nutt SL, Badie C. 2015. PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML. Carcinogenesis. 36:413–419.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.